Finance

Lists
IMRX:NASDAQ
Immuneering Corp
$4.57
-0.87%
(-0.040) 1D
$4.65
+1.75% (+0.080)
After hours
Closed: Sep 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for IMRX...
Open
$4.53
High
$4.68
Low
$4.47
Mkt. cap
295.67M
Avg. vol.
669.50K
Volume
25.00
52-wk high
$10.08
52-wk low
$3.86
EPS
-$1.03
Beta
0.40
Shares outstanding
64.70M
No. of employees
57
Open
$4.53
High
$4.68
Low
$4.47
Mkt. cap
295.67M
Avg. vol.
669.50K
Volume
25.00
52-wk high
$10.08
52-wk low
$3.86
EPS
-$1.03
Beta
0.40
Shares outstanding
64.70M
No. of employees
57
News stories
From web sources and news partners
About Immuneering Corp
CEO-
Employees57
Founded2008
Headquarters-
SectorBiotechnology
Websiteimmuneering.com
Analyst ratings
Based on 5 analysts giving stock ratings to IMRX in the past 3 months
Strong buy
Buy
5
Hold
0
Sell
0
12-month forecast
Based on 5 Wall Street analysts offering 12 month price targets for IMRX in the last 3 months.
Highest
Current $4.57
$18.00 (+293.87%)
Average
$14.60 (+219.47%)
Lowest
$12.00 (+162.58%)
Analyst
Recommendation
Action
Price target
Projected
Date
Andres Y. Maldonado
H.C. Wainwright
Buy
Maintained
$14.00
+206.3%
08/27/2026
Allison Bratzel
Piper Sandler
Buy
Maintained
$12.00
+162.6%
08/17/2026
Graig Suvannavejh
Mizuho Securities
Buy
Maintained
$12.00
+162.6%
08/06/2026
Ami Fadia
Needham
Buy
Reiterated
$18.00
+293.9%
08/05/2026
Li Watsek
Cantor Fitzgerald
Buy
Initiated
$17.00
+272%
07/08/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
$20.00
+337.6%
05/19/2026
Jay Olson
Oppenheimer
Buy
Reiterated
$30.00
+556.5%
03/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.87M
9.25M
10.65M
14.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.51M
4.49M
4.68M
5.00M
Operating expense
15.38M
13.75M
15.34M
19.00M
Total operating expenses
15.38M
13.75M
15.34M
19.00M
Operating income
-15.38M
-13.75M
-15.34M
-19.00M
Other non operating income
-
155.92K
109.01K
647.20K
EBT including unusual items
-14.96M
-11.58M
-13.46M
-17.27M
EBT excluding unusual items
-14.96M
-11.74M
-13.87M
-17.27M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-14.96M
-11.58M
-13.46M
-17.27M
Net profit margin
-
-
-
-
Earnings per share
-0.38
-0.18
-0.21
-0.27
Interest and investment income
415.83K
1.86M
1.36M
1.08M
Interest expense
-
-
-
-
Net interest expenses
415.83K
1.86M
1.36M
1.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-15.29M
-13.67M
-15.25M
-18.91M
Gain or loss from assets sale
-
2.09K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps